Hester Biosciences Limited (BOM: 524669)
India
· Delayed Price · Currency is INR 2,461.70
+43.15 (1.78%)
At close: Sep 10, 2024
Hester Biosciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 9, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 20,941 | 11,818 | 12,934 | 23,099 | 16,306 | 7,869 | Upgrade
|
| Market Cap Growth | 38.68% | -8.63% | -44.00% | 41.66% | 107.21% | -40.14% | Upgrade
|
| Enterprise Value | 23,343 | 14,503 | 15,490 | 24,167 | 17,452 | 8,539 | Upgrade
|
| Last Close Price | 2461.70 | 1385.90 | 1509.77 | 2684.30 | 1886.89 | 906.78 | Upgrade
|
| PE Ratio | 107.43 | 62.42 | 48.23 | 58.07 | 46.62 | 26.44 | Upgrade
|
| PS Ratio | 6.80 | 3.80 | 4.65 | 9.37 | 7.49 | 4.19 | Upgrade
|
| PB Ratio | 7.18 | 3.90 | 4.48 | 8.64 | 6.91 | 3.81 | Upgrade
|
| P/FCF Ratio | - | 49.79 | -23.88 | -26.55 | 94.19 | -21.43 | Upgrade
|
| P/OCF Ratio | - | 24.55 | 54.82 | 265.14 | 28.09 | 21.40 | Upgrade
|
| EV/Sales Ratio | 7.64 | 4.66 | 5.57 | 9.80 | 8.02 | 4.55 | Upgrade
|
| EV/EBITDA Ratio | 34.31 | 24.17 | 24.81 | 33.90 | 24.23 | 14.22 | Upgrade
|
| EV/EBIT Ratio | 45.01 | 33.63 | 36.86 | 43.91 | 29.52 | 18.22 | Upgrade
|
| EV/FCF Ratio | - | 61.10 | -28.60 | -27.78 | 100.81 | -23.25 | Upgrade
|
| Debt / Equity Ratio | 0.81 | 0.81 | 0.95 | 0.85 | 0.47 | 0.61 | Upgrade
|
| Debt / EBITDA Ratio | 3.82 | 4.06 | 4.38 | 3.19 | 1.52 | 2.10 | Upgrade
|
| Debt / FCF Ratio | - | 10.30 | -5.06 | -2.62 | 6.36 | -3.43 | Upgrade
|
| Asset Turnover | - | 0.47 | 0.45 | 0.51 | 0.55 | 0.55 | Upgrade
|
| Inventory Turnover | - | 1.24 | 1.03 | 0.99 | 0.84 | 0.53 | Upgrade
|
| Quick Ratio | - | 0.94 | 0.68 | 0.85 | 1.15 | 0.98 | Upgrade
|
| Current Ratio | - | 2.03 | 1.53 | 2.01 | 2.63 | 1.91 | Upgrade
|
| Return on Equity (ROE) | - | 7.16% | 10.09% | 15.69% | 15.68% | 16.00% | Upgrade
|
| Return on Assets (ROA) | - | 4.05% | 4.26% | 7.07% | 9.27% | 8.54% | Upgrade
|
| Return on Capital (ROIC) | 5.38% | 4.86% | 4.96% | 8.18% | 10.89% | 9.71% | Upgrade
|
| Earnings Yield | 0.93% | 1.60% | 2.06% | 1.70% | 2.11% | 3.71% | Upgrade
|
| FCF Yield | 2.01% | -4.19% | -3.77% | 1.06% | -4.67% | Upgrade
| |
| Dividend Yield | 0.24% | 0.43% | 0.53% | 0.37% | 0.53% | 0.73% | Upgrade
|
| Payout Ratio | 0.00% | 36.03% | 31.95% | 21.64% | 16.31% | 20.41% | Upgrade
|
| Buyback Yield / Dilution | -11.58% | - | - | - | - | - | Upgrade
|
| Total Shareholder Return | -11.33% | 0.43% | 0.53% | 0.37% | 0.53% | 0.73% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.